{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:34:56Z","timestamp":1759412096847},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T00:00:00Z","timestamp":1225324800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by routine immunization using Oral Polio Vaccine (OPV). On 21 June 2002 the WHO European Region was declared polio-free. In 2008 poliomyelitis is still endemic in 4 countries (Nigeria, India, Pakistan, and Afghanistan), where 1201 new cases were registered in 2007; 107 sporadic cases were also notified in countries where poliovirus is not endemic. The aim of this work was to verify the level of antipoliomyelitis immunity status in children and adolescents in the Apulia region (south of Italy), which may be considered a border region due to its position.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>704 blood specimens from a convenience sample were collected in six laboratories. The age of subjects enrolled was 0\u201315 years. The immunity against poliomyelitis was evaluated by neutralizing antibody titration in tissue culture microplates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Seropositivity (neutralising antibodies titre \u2265 8) for polioviruses 1, 2 and 3 was detected in 100%, 99.8% and 99.4% of collected sera. Antibody titres were not lower in subjects who received either four doses of inactivated polio vaccine (IPV) or a sequential schedule consisting of two doses of IPV and two of oral polio vaccine than in subjects who received four doses of OPV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results confirmed current data of vaccine coverage for poliomyelitis: during the last ten years in Apulia, the coverage in 24 months old children was more than 90%. The high level of immunization found confirms the effectiveness both of the sequential schedule IPV-OPV and of the schedule all-IPV. Apulia region has to face daily arrivals of refugees and remains subject to the risk of the importation of poliovirus from endemic areas. Surveys aimed at determining anti-polio immunity in subpopulations as well as in the general population should be carried out.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-8-150","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T19:14:22Z","timestamp":1225394062000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)"],"prefix":"10.1186","volume":"8","author":[{"given":"Silvio","family":"Tafuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Prato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Calvario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Labianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Luigi","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Germinario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,30]]},"reference":[{"key":"741_CR1","volume-title":"Global Eradication of Poliomyelitis by the year 2000: resolution of the 41st World Health Assembly","author":"World Health Assembly GSWHO","year":"1988","unstructured":"World Health Assembly GSWHO: Global Eradication of Poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. 1988, Geneva (Switzerland): World Health Organization, (Resolution WHA4128)"},{"issue":"1","key":"741_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/infdis\/175.Supplement_1.S183","volume":"175","author":"ME Birmingham","year":"1997","unstructured":"Birmingham ME, Aylward RB, Cochi SL, Hull HF: National immunization days: state of the art. J Infect Dis. 1997, 175 (1): 183-188.","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"741_CR3","first-page":"65","volume":"21","author":"CA De Quardos","year":"1994","unstructured":"De Quardos CA, Andrus JK, Olive JM, Carrasco P: Strategies for poliomyelitis eradication in developing countries. Public Health Rev. 1994, 21 (1\u20132): 65-78.","journal-title":"Public Health Rev"},{"issue":"1\u20132","key":"741_CR4","first-page":"117","volume":"21","author":"G Oblapenko","year":"1994","unstructured":"Oblapenko G: Poliomyelitis eradication in Europe: programme and activities. Public Health Rev. 1994, 21 (1\u20132): 117-127.","journal-title":"Public Health Rev"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(05)65063-5","volume":"349","author":"SG Wassilak","year":"1997","unstructured":"Wassilak SG, Oblapenko GP, Dittmann S, Aylward RB, Hull HF: Poliomyelitis vaccination strategies for Europe. Lancet. 1997, 349: 437-10.1016\/S0140-6736(05)65063-5.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"741_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/infdis\/175.Supplement_1.S76","volume":"175","author":"G Oblapenko","year":"1997","unstructured":"Oblapenko G, Sutter RW: Status of poliomyelitis eradication in Europe and the Central Asia Republics fo the Former Soviet Union. J Infect Dis. 1997, 175 (Suppl 1): 76-81.","journal-title":"J Infect Dis"},{"issue":"12","key":"741_CR7","first-page":"1445","volume":"121","author":"JM Borgono","year":"1993","unstructured":"Borgono JM: International Committee for the Certification of Poliomyelitis Eradication (letter). Rev Med Chil. 1993, 121 (12): 1445-","journal-title":"Rev Med Chil"},{"issue":"7","key":"741_CR8","first-page":"45","volume":"69","author":"WHO, Geneva","year":"1994","unstructured":"WHO, Geneva: Expanded Programme on Immunization (EPI). Poliomyelitis eradication. Wkly Epidemiol Rec. 1994, 69 (7): 45-7.","journal-title":"Wkly Epidemiol Rec"},{"key":"741_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(97)80066-9","volume":"349","author":"D Greco","year":"1997","unstructured":"Greco D, Fiore L, Sallabanda A, Diamanti H: Poliomyelitis vaccination strategies for Europe. Lancet. 1997, 349: 437-10.1016\/S0140-6736(97)80066-9.","journal-title":"Lancet"},{"key":"741_CR10","unstructured":", [http:\/\/www.polioeradication.org\/casecount.asp]"},{"key":"741_CR11","volume-title":"Global polio eradication initiative strategic plan 2004\u20132008","author":"WHO","year":"2004","unstructured":"WHO: Global polio eradication initiative strategic plan 2004\u20132008. 2004, Geneva:WHO"},{"key":"741_CR12","first-page":"739","volume":"66","author":"K Esteves","year":"1988","unstructured":"Esteves K: Safety of oral poliomyelitis vaccine: results of a WHO enquiry. Bull World Health Organ. 1988, 66: 739-46.","journal-title":"Bull World Health Organ"},{"key":"741_CR13","first-page":"625","volume-title":"Vaccines","author":"SA Plotkin","year":"2004","unstructured":"Plotkin SA, Vidor E: Poliovirus vaccine-inactivated. Vaccines. Edited by: Plotkin SA, Orenstein WA. 2004, Philadelphia: Saunders, 625-49. 4","edition":"4"},{"key":"741_CR14","first-page":"356","volume":"296","author":"O Kew","year":"2002","unstructured":"Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andr\u00e9 J, et al: Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Sciente. 2002, 296: 356-9.","journal-title":"Sciente"},{"key":"741_CR15","doi-asserted-by":"publisher","first-page":"13512","DOI":"10.1128\/JVI.78.24.13512-13521.2004","volume":"78","author":"H Shimizu","year":"2004","unstructured":"Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, et al: Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol. 2004, 78: 13512-21. 10.1128\/JVI.78.24.13512-13521.2004.","journal-title":"J Virol"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3201\/eid0907.020692","volume":"9","author":"D Rousset","year":"2003","unstructured":"Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Balanant J, Delpeyroux F: Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis. 2003, 9: 885-7.","journal-title":"Emerg Infect Dis"},{"key":"741_CR17","doi-asserted-by":"publisher","first-page":"8366","DOI":"10.1128\/JVI.77.15.8366-8377.2003","volume":"77","author":"CF Yang","year":"2003","unstructured":"Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al: Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003, 77: 8366-77. 10.1128\/JVI.77.15.8366-8377.2003.","journal-title":"J Virol"},{"key":"741_CR18","first-page":"1053","volume":"54","author":"Center for Disease Control and Prevention","year":"2005","unstructured":"Center for Disease Control and Prevention: Poliovirus Infections in four unvaccinated children-Minnesota August-October 2005. MMWR Morb Moral Wkly Rep. 2005, 54: 1053-5.","journal-title":"MMWR Morb Moral Wkly Rep"},{"key":"741_CR19","unstructured":"Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine using countries. Wkly Epidemiol Rec. 78 (28): 241-50. 2003 Jul 11"},{"key":"741_CR20","doi-asserted-by":"crossref","unstructured":"Alexander LN, Steward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, et al: Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 292 (14): 1696-701. 10.1001\/jama.292.14.1696. 2004 Oct 12","DOI":"10.1001\/jama.292.14.1696"},{"key":"741_CR21","unstructured":"Ministero della Salute, Italia: Circolare n 5. 7 April 1999"},{"key":"741_CR22","unstructured":"Conferenza permanente per i rapporti tra lo Stato, le Regioni e le Province Autonome di Trento e Bolzano, 30 may. 2002, . Accordo tra il Ministero della Salute, le Regioni e le Province Autonome di Trento e Bolzano sulle modifiche al calendario della vaccinazione anti-poliomielitica"},{"key":"741_CR23","unstructured":"Ministero della Salute, Italia, Piano Nazionale Vaccini 2005-Gazzetta Ufficiale Repubblica Italiana, Suppl. Ordinario,14 april 2005. 2007"},{"issue":"9","key":"741_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0929-693X(03)00409-3","volume":"10","author":"J Gaudelus","year":"2003","unstructured":"Gaudelus J, Ovetichkine P, Cheymol J, De Courson F, Allaert FA: Compliance with the vaccination recommendations for o- to 24-month-old infants in general or paediatric pratice. Arch Pediatr. 2003, 10 (9): 781-6. 10.1016\/S0929-693X(03)00409-3.","journal-title":"Arch Pediatr"},{"key":"741_CR25","unstructured":"Ministero della Salute, rilevazione routinaria delle coperture vaccinali. visited on 6 may 2008 at 10.18, [http:\/\/www.ministerosalute.it]"},{"issue":"6\/7","key":"741_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0264-410X(96)00208-3","volume":"15","author":"I Mastroeni","year":"1997","unstructured":"Mastroeni I, Patti AM, Fabrizi A, Santi AL, Manduca AM, Vescia N, et al: Immunity status against poliomyelitis in persons 13\u201314 years old living in Rome. Vaccine. 1997, 15 (6\/7): 747-50. 10.1016\/S0264-410X(96)00208-3.","journal-title":"Vaccine"},{"key":"741_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1023\/A:1007331900645","volume":"13","author":"A Pianetti","year":"1997","unstructured":"Pianetti A, Salvaggio L, Biffi MR, Baffone W, Bruscolini F, de Donato S, Albano A: Antipoliomyelitis immunity status in cohort of young men drafted into military service, residing in the suburban Milan area. Eur J Epidemiol. 1997, 13: 725-27. 10.1023\/A:1007331900645.","journal-title":"Eur J Epidemiol"},{"key":"741_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2310\/7060.2000.00040","volume":"7","author":"PL Lopalco","year":"2000","unstructured":"Lopalco PL, Germinario C, Calvario A, Chironna M, Quarto M, Barbuti S: High level of immunity against Poliomyelitis in Albanian refugees in Southern Italy. J Travel Med. 2000, 7: 111-115.","journal-title":"J Travel Med"},{"issue":"6","key":"741_CR29","first-page":"487","volume":"14","author":"R Prato","year":"2002","unstructured":"Prato R, Labianca M, Calvario A, Bozzi A, Rizzo C, Fiore L, et al: Evaluation of the Surveillance System of Acute Flaccid Paralysis in Puglia: 5 years of work. Ann Ig. 2002, 14 (6): 487-94.","journal-title":"Ann Ig"},{"key":"741_CR30","first-page":"44","volume-title":"Expanded Programme on Immunization (WHO-EPI-CDC-Polio-90.1). Manual for the Virological Investigation of Poliomyelitis","author":"WHO","year":"1990","unstructured":"WHO: Expanded Programme on Immunization (WHO-EPI-CDC-Polio-90.1). Manual for the Virological Investigation of Poliomyelitis. 1990, Geneva; WHO, 44-65."},{"key":"741_CR31","first-page":"353","volume":"11","author":"AM Patti","year":"1999","unstructured":"Patti AM, Santi AL, Bellucci C, Ciappetti C, Fara GM, Germinario C, et al: Serological survey on immunit\u00e0 status againist polioviruses in Italian young adults and in immigrants. Ann Ig. 1999, 11: 353-359.","journal-title":"Ann Ig"},{"key":"741_CR32","first-page":"210","volume":"58","author":"G Stagni","year":"1979","unstructured":"Stagni G, Merletti L, De Rosa F: Livelli di anticorpi specifici per i virus poliomielitici e grado di protezione immunitaria nella popolazione umbra. Boll Ist Sieroter Milan. 1979, 58: 210-15.","journal-title":"Boll Ist Sieroter Milan"},{"key":"741_CR33","first-page":"275","volume":"54","author":"A Volpi","year":"1976","unstructured":"Volpi A, Ragona G, Biondi W, Rocchi G, Archetti I: Seroimmunity to polioviruses in an urban population of Italy. Wld Htl Org Bull. 1976, 54: 275-78.","journal-title":"Wld Htl Org Bull"},{"key":"741_CR34","first-page":"12","volume":"47","author":"S Majori","year":"2006","unstructured":"Majori S, Baldo V, Poli A, Riolfatti M, Alborino F, Bonello C, et al: Immunity to poliovirus among children and the elderly in north-east Italy. J Prev Med and Hyg. 2006, 47: 12-15.","journal-title":"J Prev Med and Hyg"},{"issue":"1","key":"741_CR35","first-page":"47","volume":"82","author":"PE Fine","year":"2004","unstructured":"Fine PE, Oblapenko G, Sutter RW: Polio control after certification: major issues outstanding. Bull World Health Organ. 2004, 82 (1): 47-52. Epub 2004 Feb 26","journal-title":"Bull World Health Organ"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-8-150\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-8-150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:20:47Z","timestamp":1630488047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-8-150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,30]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-8-150","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,30]]},"assertion":[{"value":"28 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"150"}}